Related Experiment Video
Updated: Jul 3, 2026
04:00
A Matrigel-Based Tube Formation Assay to Assess the Vasculogenic Activity of Tumor Cells
Published on: September 7, 2011
66.3K
[Vasculogenic mimicry]
E Z Lapkina1, A R Esimbekova1, T G Ruksha1
1Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia.
Arkhiv Patologii
|November 27, 2023
Summary
Vasculogenic mimicry, a tumor blood supply variant, hinders anti-cancer drug effectiveness. Targeting its pathways, influenced by the tumor microenvironment, offers new therapeutic strategies for aggressive cancers.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment Research
Background:
- Anti-angiogenic drugs are standard cancer therapies.
- Vasculogenic mimicry (VM) is a tumor neoangiogenesis variant in aggressive cancers.
- VM formation correlates with reduced anti-cancer therapy effectiveness.
Approach:
- This review synthesizes current research on VM mechanisms in malignant neoplasms.
- It examines the role of the tumor microenvironment, including macrophages and fibroblasts, in VM.
- Signaling pathways regulating VM channel formation are characterized.
Key Points:
- VM provides an alternative tumor blood supply route.
- The tumor microenvironment significantly influences VM development.
- Specific signaling pathways are critical for VM formation.
Conclusions:
- Understanding VM mechanisms is crucial for improving cancer treatment.
- Targeting molecular pathways involved in VM presents a promising strategy.
- Interfering with VM can potentially enhance the efficacy of antitumor therapies.
More Related Videos
Related Concept Videos
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:19Imaging Studies VII: Vascular Imaging
DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
01:21Cytotoxic Edema: Pathophysiology
Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...